Aptorum Group Limited to Present at the Solebury Trout Virtual Investor Conference
30 Marzo 2020 - 7:01AM
JCN Newswire (English)
HONG KONG, Mar 30, 2020 - (ACN Newswire) - Aptorum Group
Limited to Present at the Solebury Trout Virtual Investor
ConferenceAptorum Group Limited (NASDAQ:APM) ("Aptorum Group"), a
biopharmaceutical company focused on the development of novel
therapeutics to address global unmet medical needs, today announced
that Ian Huen, Chief Executive Officer and Executive Director, and
Darren Lui, President and Executive Director, will present at the
Solebury Trout Virtual Investor Conference on Thursday, April 2, at
12:00 pm ET. The conference will webcast at the Solebury Trout
website
(https://78449.themediaframe.com/dataconf/productusers/solebury/mediaframe/36519/indexl.html).
The presentation length would be 25 minutes.
The Company's presentation will be archived on the "Events
Calendar" page in the Investor section of the Company's website at
www.aptorumgroup.com.
About Aptorum Group Limited
Aptorum Group Limited (Nasdaq:APM) is a pharmaceutical company
dedicated to developing and commercializing novel therapeutics to
tackle unmet medical needs. Aptorum Group is pursuing therapeutic
projects in orphan diseases, infectious diseases, metabolic
diseases and other disease areas.
For more information about Aptorum Group, please visit
http://www.aptorumgroup.com.
Disclaimer and Forward-Looking Statements
This press release includes statements concerning Aptorum Group
Limited and its future expectations, plans and prospects that
constitute "forward-looking statements" within the meaning of the
Private Securities Litigation Reform Act of 1995. For this purpose,
any statements contained herein that are not statements of
historical fact may be deemed to be forward-looking statements. In
some cases, you can identify forward-looking statements by terms
such as "may," "should," "expects," "plans," "anticipates,"
"could," "intends," "target," "projects," "contemplates,"
"believes," "estimates," "predicts," "potential," or "continue," or
the negative of these terms or other similar expressions. Aptorum
Group has based these forward-looking statements, which include
statements regarding projected timelines for application
submissions and trials, largely on its current expectations and
projections about future events and trends that it believes may
affect its business, financial condition and results of operations.
These forward-looking statements speak only as of the date of this
press release and are subject to a number of risks, uncertainties
and assumptions including, without limitation, risks related to its
announced management and organizational changes, the continued
service and availability of key personnel, its ability to expand
its product assortments by offering additional products for
additional consumer segments, development results, the company's
anticipated growth strategies, anticipated trends and challenges in
its business, and its expectations regarding, and the stability of,
its supply chain, and the risks more fully described in Aptorum
Group's Form 20-F and other filings that Aptorum Group may make
with the SEC in the future. As a result, the projections included
in such forward-looking statements are subject to change. Aptorum
Group assumes no obligation to update any forward-looking
statements contained in this press release as a result of new
information, future events or otherwise.
Contacts
Investors:
Tel: +852 2117 6611
Email: investor.relations@aptorumgroup.com
Media:
Tel: + 852 2117 6611
Email: info@aptorumgroup.com
Source: Aptorum Group Limited
Copyright 2020 ACN Newswire . All rights reserved. |
Aptorum (NASDAQ:APM)
Gráfica de Acción Histórica
De Mar 2024 a Abr 2024
Aptorum (NASDAQ:APM)
Gráfica de Acción Histórica
De Abr 2023 a Abr 2024